FDA'S NEW DRUG REVIEW PROCESS: AN OVERVIEW FROM OFFICIAL WEBSITE

Journal Title: Journal of Drug Discovery and Therapeutics - Year 2013, Vol 1, Issue 4

Abstract

Drugs are the vital and inevitable part of modern day treatment strategies. Drugs are always directly related with lives of human beings. There should be very strict approval process before getting permission for their marketing and ultimate licence for use of humans. FDA (U.S. Food and Drug Administration) is an agency which plays a vital role in the approval of millions of drug for market distribution and selling purposes. FDA’s Centre for Drug Evaluation and Research (CDER) is involved in the process of innovation and development of new drugs. Any new drug which is being invented always needs to go through the FDA’s guidelines mentioned in this review. All the data mentioned in this review has been taken from the official website of FDA just for the simplification of the original procedure mentioned on the website.

Authors and Affiliations

Dr. Satish Bahekar*| Demonstrator, Department of Pharmacology, Mahatma Gandhi Institute of Medical Sciences, Sewagram Wardha, Maharashtra 442102, India, Dr. Ranjana Kale| Professor, Department of Pharmacology, Mahatma Gandhi Institute of Medical Sciences, Sewagram Wardha, Maharashtra 442102, India

Keywords

Related Articles

Breast Cancer Vaccine – Prioritizing Deterrence

The control of the immune system through the administration of avaccine to direct a successful and enduring immune response against breast cancer cells is an alluring method. Vaccine would have a few hypothetical prefere...

A review on recent advances of oral mouth dissolving tablet

Mouth dissolving tablets are disintegrating and dissolve rapidly in mouth cavity without need of water. Many tablets are design to dissolve in mouth fast in few second and other true fast dissolving tablets. Oral mouth d...

Enhancement of Hepatoprotective Effect of Herbal Formulation (F1) on Carbon tetrachloride and Ethanol Induced Liver Toxicity in Albino Rats

There are several plants and formulations which are recommended for the treatment of liver diseases. The formulation F1 was composed with Andrographis paniculata (Kalmegh), Boerhavia diffusa (Punarnava), Eclipta alba (Bh...

STUDY TO EVALUATE PRESCRIPTION PATTERNS AND KNOWLEDGE ABOUT COMMON ALLOPATHIC DRUGS AMONG UNQUALIFIED RURAL MEDICAL PRACTITIONERS

AIMS AND OBJECTIVES: To evaluate the prescription patterns and knowledge about common allopathic drugs among the unqualified rural medical practitioners in Pinjore block of Panchkula district, Haryana MATERIAL AND METHOD...

One pot conventional synthesis and biological activity of some novel double schiff bases

In this work, we report the synthesis and biological activity of some new double Schiff bases derived from ethylene diamine with 2-acetylnaphthalene and 2-acetylpyridine and were characterised by using UV-Visible, FTIR,...

Download PDF file
  • EP ID EP1377
  • DOI -
  • Views 473
  • Downloads 29

How To Cite

Dr. Satish Bahekar*, Dr. Ranjana Kale (2013). FDA'S NEW DRUG REVIEW PROCESS: AN OVERVIEW FROM OFFICIAL WEBSITE. Journal of Drug Discovery and Therapeutics, 1(4), 40-43. https://www.europub.co.uk/articles/-A-1377